Webinar: NEW TECHNOLOGIES TO DRIVE DRUG DISCOVERY AND DEVELOPMENT
Sponsored by: Thomson Reuters
Focused on:
Date: 19th June
Days old: 4614
Time: 3PM London / 10AM New York
Introducing next generation Decision Support & Informatics solutions for Life Sciences companies
It's true, biopharma companies spend too much time gathering and collating data, resolving inconsistencies, and performing analysis for clinical development decisions. This inefficiency results in lost time in throughout the discovery and development process, wasted effort and an inability to demonstrate superior clinical outcomes to competitive therapies.
New technology solutions from Thomson Reuters can reduce time spent compiling and analyzing data giving you the data where and when you need it so you can make faster decisions to drive research and business forward. This webinar will discuss the challenges and solutions and present new technologies that will demonstrate:
• New information systems that allow you to pull high quality data directly from Thomson Reuters servers into your applications or knowledge sharing solutions, creating limitless options for integration across your organization
• New at a glance decision support tools that quickly visualize key competitive metrics
• New opportunites to integrate data within Electronic Lab Notebooks (ELNs) or other third party knowledge solutions.
Take your drug discovery team to the next level! Sign up today for this webinar today to learn how Thomson Reuters can help you increase the productivity of your discovery efforts.
Presented by
Tim Miller,
VP, Analytics
Tim Miller has worked within the Thomson Reuters organization for 29 years. After 5 years editorial work for World Patents Index he moved to Product Development where he was responsible for a number of initiatives including GENESEQ, Patents Preview, Patents Citation Index, Derwent Chemistry Resource and Derwent Discovery.
Tim specialises in the interface between Science and IT and has held various positions on both sides of the fence, including Programme Manager and Principal Architect roles in IT and Research/Product Development Director positions in the business. In his current role Tim focuses on bioinformatics, cheminformatics, semantic technologies and text/data mining & visualisation, specifically as they apply to the Pharma space. Tim holds a bachelor's degree in Chemistry from the University of York and a bachelor's degree in Law from the University of London. He is a Chartered Chemist (Member of the Royal Society of Chemistry) and a Chartered Information Technology Professional (Member of the British Computer Society)
Andreas Matern,
VP, Disruptive Innovation
Thomson Reuters Andreas Matern has been working with and for the life science industry as a bioinformatics expert for over ten years. He has worked on projects as diverse as delivering gene annotation data to a major pharmaceutical company to consolidating data warehouses for a multinational financial services company. Managing a team of diverse technology and scientific professionals, his main goal at Thomson Reuters is to be an evangelist for the distribution of high quality, curated content through multiple technological means.
Key Learning Objectives
- Support strategic decision making with clinical trial information
- Design applications that display Thomson Reuters content together with your proprietary data any way you want it
- Reduce time spent compiling and analyzing data
- Discover how new technologies are delivering faster and more accurate insight into your development challenges
Audience
- CEO/President/Chairman/Executive Director
- Therapeutic Area Heads/ clinical leads (VP
- Director)
- Business Unit VPs
- VP Clinical Development
- VP R&D Informatics
- Disease area directors
- Principal Scientists
- Medical Affairs